Ibotta, Inc. Logo

Ibotta, Inc.

A performance marketing platform offering cash-back rewards to consumers from CPG brands.

IBTA | US

Overview

Corporate Details

ISIN(s):
US4510511060
LEI:
Country:
United States of America
Address:
1801 CALIFORNIA STREET, SUITE 400, 80202 DENVER
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ibotta, Inc., founded in 2012, is a performance marketing company that operates a platform for digital promotions. The company primarily serves consumer packaged goods (CPG) brands by delivering targeted offers to a network of over 200 million consumers through its proprietary Ibotta Performance Network (IPN). Its core consumer-facing product is a free mobile application that allows users to earn cash-back rewards on everyday purchases, such as groceries. Users select offers, make purchases in-store or online, and submit proof of purchase to receive cash rewards. This model enables brands to drive sales while providing Ibotta with valuable consumer purchasing data.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ibotta, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ibotta, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ibotta, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan
4564

Talk to a Data Expert

Have a question? We'll get back to you promptly.